Results

Total Results: 1,651 records

Showing results for "described".

201. Depression-Postpartum-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
     May 01, 2013 - In addition, we described comparators carefully, as intervention and assessment standards may have … We applied criteria for each study type derived from core elements described in the Methods Guide. … These 45 articles described 40 unique studies. … Because of the inconsistency in how specific risk factors were described in the studies, we were unable … As described above, even a simple model can be helpful in illustrating tradeoffs and can highlight

202. Rapid Evidence Product Patient Navigation Models For Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-navigation-model-lung-cancer-rapid.pdf
     December 01, 2018 - While tradeoffs will likely differ for each topic, they are described so readers can adjudicate the … For Question 1, we included studies that explicitly described models for patient navigation or described … Our search for primary studies identified six13-18 that described components of the Patient Navigation … medical centers, and a mix of community and public hospitals Patient navigation models were not described … Primary Studies of the PNRP Entry criteria were better described than exit criteria in the PNRP studies

203. Heart-Failure-Transition-Care Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_executive.pdf
     May 01, 2014 - They are not delivered primarily through a clinic-based intervention (described above). … Usual care was somewhat heterogeneous across trials and often not well described. … In particular, as described above, direct evidence was insufficient to permit us to draw conclusions … Sometimes usual care and certain aspects of treatment interventions were not adequately described. … Moreover, some confounding components that were not described may be associated with efficacy as well

204. DST_Draft_Protocol_Nov_4_2013_clean (2) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
     November 12, 2013 - explicit; whether the DST is provided during a consultation session or not; and other categorizations described … Figure 1: This figure depicts the key questions (KQs) within the context of the PICOTS described in … interventions, comparators, outcomes, timing, settings, and study designs and setting (PICOTS) as described … Abstract and full-text screening will be performed as described above. … events, and for factors affecting (modifying) the treatment effect among subgroups of patients, as described

205. Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
     January 15, 2015 - artery anatomic structure (including deposition of plaque), vascular function, and myocardial function described … The definitions of risk categories are based on those described in the ACCF/AHA 2012 Guideline.8 In … CAD, where there is literature using it as a referent in the population of interest it will also be described … The strength of the evidence may be downgraded based on the limitations described above. … effect, presence of dose-response relationship or existence of plausible unmeasured confounders) as described

206. Disposition of Comments CER 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
     March 19, 2018 - March 19, 2018 7 Commentator & Affiliation Section Comment Response Peer reviewer #2 Well described … Peer reviewer #3 Very detailed and described the entire process ‐ well done. … In addition the mechanisms of action of these various drugs are not described. … 19, 2018 12 Commentator & Affiliation Section Comment Response TEP reviewer #3 This is well described … Peer reviewer #2 The data to address the key questions are well‐ described and conclusions can be reached

207. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
     January 01, 2013 - Slide 1 Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research …

208. Disposition of Comments for CER 159 Insomnia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
     December 30, 2015 - We described specific adverse effects in the text. … Characteristics of the study are clearly described. … Studies are clearly described. The key messages are also clearly described. … The limitations are also adequately described. … Limitations are described. Thank you.

209. Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
     August 23, 2012 - Studies included are reasonably described. Most do not report race/ethnicity. … The characteristics of the studies are clearly described in the evidence tables. … The current use of other inhalational gases is described in Table 1. … Apgar scoring is described earlier in the section. … The limitations are described adequately. The table of evidence is useful for this.

210. Disposition of Comments Report for Otitis Media With Effusion (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
     May 04, 2013 - However, inexplicably, none of the actual findings were described in the Browning et al text. … This phrase was written in relation to meta- analyses that were described by the authors as combining … ES-10, lines 14-15: States that functional outcomes are described under KQ1--where? … It's overstated and not in consideration of the mixed evidence that is later described. … Peer Reviewer #9 Results The data and results are very well described.

211. Disposition of Comments for Comparative Effectiveness Review 133 Transitional Care Interventions To Prevent Readmissions for People With Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
     May 27, 2014 - The determination of ‘level of intensity’ was not very well described (unless I missed it). … Some reviewers wanted to see additional detail not described in the text. … The main findings are well described in the Executive Summary, and specific details are elaborated … Thank you. 212 Peer Reviewer 14 Results The characteristics of the studies are clearly described … Thank you. 273 Peer Reviewer 14 Discussion The limitations of the review/studies are described

212. Disposition of Comments_Comparative Effectiveness Review No. 246: Management of High-Need, High-Cost Patients: A "Best Fit" Framework Synthesis, Realist Review, and Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
     October 29, 2021 - clarifications, additions, deletions, and corrections; changes made to the report in response are described

213. Alcohol-misuse-drug-therapy-140326 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
     January 27, 2012 - For the purposes of this report, we use the definitions described in Table 1. Table 1. … were mainly in substance abuse treatment settings, and cointerventions (e.g., counseling) were not described … The steps that we will take to accomplish the literature review are described below. … Appropriateness will be determined by the same methods described above. C. … As described above, all results will be tracked in an EndNote database.

214. C- Evidence-based Practice Center Technical Brief Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
     August 05, 2010 - The Guiding Questions and methods of this technical brief are described herein. II. … Data to be abstracted for answering Key Question 3 are described in section III.2.A. … All Key Informants will be informed beforehand of the audio recording process as described above.

215. Bar-Cohen II_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/bar-cohen-ii_eccs2012.pdf
     January 01, 2012 - prevention  and  risk. o 25% of the  stories  were  on screening; 6 of the  9 stories  that described

216. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - for prostate cancer Format: booklet (not available for review) Approach to translating evidence not described

217. Methods-Guidance-Applicability Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
     January 01, 2011 - Critical concerns about applicability, however, can and should be described in the text. … Although the exact process needs to be flexible and will likely evolve, attention to the general concepts described

218. Methods Guide Atkins (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
     January 01, 2011 - Critical concerns about applicability, however, can and should be described in the text. … Although the exact process needs to be flexible and will likely evolve, attention to the general concepts described

219. Appendix K Rapid Evidence Review Treatments for Clostridium difficile Colitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
     February 01, 2018 - Search terms described Yes 2. Two or more databases Yes 3. Inclusion/exclusion criteria Yes 4. … Studies described in evidence table Yes 11. … Australasian Society of Infectious Diseases (ASID) 20164 Evidence rating: None described or presented … Recommendation rating: None described or presented 3. … NICE9 Evidence rating: None described or presented Recommendation rating: None described or presented

220. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
     January 01, 2024 - Program Methods Guide (https://effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview), as described … Results The included RCTs are described in Table B and the included observational studies are described